134 related articles for article (PubMed ID: 11949057)
1. Tamoxifen. To take or not to take. That is the question.
Blanchard P
Tex Nurs; 1999 Aug; 73(7):4-5, 7. PubMed ID: 11949057
[No Abstract] [Full Text] [Related]
2. "I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction.
Paterniti DA; Melnikow J; Nuovo J; Henderson S; DeGregorio M; Kuppermann M; Nease R
Ethn Dis; 2005; 15(3):365-72. PubMed ID: 16108294
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen.
Nurs Times; 2006 Feb 21-27; 102(8):33. PubMed ID: 16519033
[No Abstract] [Full Text] [Related]
4. Breast cancer prevention with tamoxifen.
Haden K; Santen R
Lippincotts Prim Care Pract; 2000; 4(4):434-40. PubMed ID: 11261120
[No Abstract] [Full Text] [Related]
5. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
[TBL] [Abstract][Full Text] [Related]
6. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
[TBL] [Abstract][Full Text] [Related]
7. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
Goldenberg VK; Seewaldt VL; Scott V; Bean GR; Broadwater G; Fabian C; Kimler B; Zalles C; Lipkus IM
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1032-4. PubMed ID: 17507634
[TBL] [Abstract][Full Text] [Related]
8. [Nurse's role in chemotherapy care].
Rovelon P
Soins; 2003 Mar; (673):37-9. PubMed ID: 12677922
[No Abstract] [Full Text] [Related]
9. Breast cancer risk in primary care: implications for chemoprevention.
Lewis CL; Kinsinger LS; Harris RP; Schwartz RJ
Arch Intern Med; 2004 Sep; 164(17):1897-903. PubMed ID: 15451765
[TBL] [Abstract][Full Text] [Related]
10. Give us clear, not convoluted, clinical practice guidelines.
Sehmer J
CMAJ; 2001 Nov; 165(11):1468-9. PubMed ID: 11762568
[No Abstract] [Full Text] [Related]
11. Give us clear, not convoluted, clinical practice guidelines.
Lawrence MR
CMAJ; 2001 Nov; 165(11):1468; author reply 1469. PubMed ID: 11762569
[No Abstract] [Full Text] [Related]
12. Acceptance of tamoxifen chemoprevention by physicians and women at risk.
McKay A; Latosinsky S; Martin W
Cancer; 2005 Jan; 103(1):209-10. PubMed ID: 15540238
[No Abstract] [Full Text] [Related]
13. Tamoxifen for breast cancer prevention: safety warning.
Wooltorton E
CMAJ; 2002 Aug; 167(4):378-9. PubMed ID: 12197698
[No Abstract] [Full Text] [Related]
14. Taxanes.
Nurs Times; 2006 Jul 25-31; 102(30):37. PubMed ID: 16903306
[No Abstract] [Full Text] [Related]
15. Researchers wonder why high-risk women are not taking chemoprevention drugs.
Savage L
J Natl Cancer Inst; 2007 Jun; 99(12):913-4. PubMed ID: 17565147
[No Abstract] [Full Text] [Related]
16. Making tough decisions.
Karlowicz KA
Urol Nurs; 2004 Dec; 24(6):460, 473. PubMed ID: 15658731
[No Abstract] [Full Text] [Related]
17. Tamoxifen and beyond.
Harv Womens Health Watch; 1998 Jun; 5(10):1. PubMed ID: 9663008
[No Abstract] [Full Text] [Related]
18. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
Litsas G
Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176
[TBL] [Abstract][Full Text] [Related]
19. NCI study: more than 2 million U.S. women could benefit from tamoxifen.
FDA Consum; 2003; 37(3):7. PubMed ID: 12793384
[No Abstract] [Full Text] [Related]
20. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
Jordan VC
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
